Items Tagged with 'Daily International Pharma Alert'


Kenya May Consider HIV Drug Compulsory Licensing

Kenya is the latest country to assert that it will not let international patent protection restrict access to life-saving medicines, including HIV drugs, according to a report from the U.N. Integrated Regional Information Networks (IRIN).

Read More

MHRA Considers Widening Availability of Naproxen

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a public consultation on whether naproxen 250-mg tablets should be made available OTC for treating primary dysmenorrhoea, or period pain, for women ages 15 to 50.

Read More

Australia to Subsidize New ADHD Drug

A new drug for treating attention-deficit/hyperactivity disorder (ADHD) will be listed on Australia's Pharmaceutical Benefits Scheme (PBS) starting July 1, the Ministry of Health and Ageing announced.

Read More

Groups Call on Health Ministers to Boost HIV Treatment Coverage

A weeklong meeting of African Union (AU) health ministers is under way in Johannesburg, South Africa, and activists have expressed concern that commitments on HIV/AIDS made at meetings last year are missing from the agenda, the U.N. Integrated Regional Information Networks (IRIN) reports.

Read More

PhRMA Supports Fighting Counterfeit Drugs in China

In response to the U.S government's request for a World Trade Organization panel to investigate intellectual property rights enforcement in China, the Pharmaceutical Research and Manufacturers of America (PhRMA) issued a statement saying the move shows the U.S. government's commitment to fighting counterfeit drugs.

Read More